November 30th 2023
Lawrence Eichenfield, MD, reacts to the FDA's acceptance of a supplemental New Drug Application for roflumilast cream 0.15% to treat atopic dermatitis (AD) in patients aged 6 years and older.
The 5th Annual Advanced Practice Collaborative™
Collaborating Across the Continuum™ : Managing Relapsing MS – A Focus on the Utility of CD20-Targeted B-Cell Therapy
4th annual Precision Medicine Symposium: An Illustrated Tumor Board
Clinical Consultations™: Raising Awareness and Optimizing Treatment in Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID)
Medical Crossfire®: Ophthalmology and Oncology Perspectives on Integrating Novel Bispecific Antibodies Into the Uveal Melanoma Treatment Paradigm
Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers
Addressing Healthcare Inequities: Overcoming Challenges in the Equitable Management of Idiopathic Pulmonary Fibrosis
Oncology Town Hall™: Primary Investigators Present Key Abstracts in Gastrointestinal Malignancies from Paris
Of patients in the atopic dermatitis (AD) cohort, 36.6% developed at least 1 comorbidity amid follow-up compared to 28.5% in the non-AD reference cohort, investigators of a Sweden, nationwide, population-based cohort study found.
A recent study underscores the significant disease burden in children with sickle cell disease, urging consideration for earlier and higher-dose hydroxyurea treatment to alleviate morbidity, especially in those with HbSS/Sβ0 thalassemia.
The warning letters issued to 7 manufacturers are part of a larger, on-going effort by the FDA to address manufacturing, distribution, and sale of illegal and unauthorized e-cigarettes.
A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.
Despite efforts to enhance communication between clinics and community groups, a study finds no significant improvement in parental knowledge and attitudes toward HPV vaccination during children's primary care visits, highlighting the persistent challenge of low vaccine uptake in the United States.
A total of 3761 cases of congenital syphilis were reported to the CDC in 2022, with the lack of timely testing and adequate treatment contributing to 88% of these cases.